-
In vivo metabolite identification and safety evaluation of human metabolites
To support understanding whether the drug metabolites can be considered safe, […]
-
New article on physiologically based pharmacokinetic modeling
Admescope’s top expert on physiologically based pharmacokinetic (PBPK) modeling, Dr Aki Heikkinen, […]
-
Admescope team welcomes a new CEO!
We are excited to announce Admescope team growing with an appointment of Dr […]
-
Do you need support with your Biologics project?
Admescope has been providing research services for biologics over few years now. We […]
-
New Admescope e-book is out!
Since Admescope’s previously published six e-books have been taken very well […]
-
Press Release: Symeres, a leading European CRO and CDMO, joins forces with Keensight Capital
We are pleased to let you know that Keensight Capital, one […]
-
An upcoming webinar via Symeres – In vivo pharmacokinetic experiments in preclinical drug development
Are you planning to initiate PK studies or just willing to […]
-
Admescope continues to be highly rated by the customers!
The whole Admescope team wishes to thank all our customers, who […]
-
Don’t neglect the metabolites!
Even though the focus of research in drug discovery & development […]
-
MIST webinar and new publication
Metabolites in safety testing (MIST) webinar Dr Johanna Haglund, Head of […]
-
Characterisation of antibody-drug conjugates
We are happy to continue updating you about the developments in […]
-
Admescope – A Symeres Company
Earlier this month, we were happy to inform you about the […]
Feel free to contact us!
Curious to know more about what can we do for you? Get in touch and let’s start a conversation.